Matches in Wikidata for { <http://www.wikidata.org/entity/Q92774473> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q92774473 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q92774473 description "scientific article published on 15 June 2019" @default.
- Q92774473 description "wetenschappelijk artikel" @default.
- Q92774473 description "наукова стаття, опублікована 15 червня 2019" @default.
- Q92774473 name "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 name "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 type Item @default.
- Q92774473 label "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 label "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 prefLabel "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 prefLabel "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 P1433 Q92774473-15B8C1F6-C951-48E8-8EB5-9ECFFEAAE5F2 @default.
- Q92774473 P1476 Q92774473-C7AE3491-299B-458B-86FD-28D7BD74E0FE @default.
- Q92774473 P2093 Q92774473-13170C47-C600-44B0-AE0B-B5B22EC65463 @default.
- Q92774473 P2093 Q92774473-160BCF61-7A1F-4D04-86EB-8970F26A8946 @default.
- Q92774473 P2093 Q92774473-326D0A17-AB81-4004-BA3E-BF32611919B7 @default.
- Q92774473 P2093 Q92774473-6A38EBD8-B687-4959-9F2D-BA1CA2B5C600 @default.
- Q92774473 P2093 Q92774473-BA723FA0-CF50-4D07-9F13-71C25F2D7B12 @default.
- Q92774473 P2093 Q92774473-D085E436-0B9B-401B-9CF7-E782E7A0A22F @default.
- Q92774473 P2093 Q92774473-D630FCBE-A405-4429-8D31-50D784DA5695 @default.
- Q92774473 P2093 Q92774473-F4051F1B-FCC6-4F4A-932D-06BC2CD50FF8 @default.
- Q92774473 P304 Q92774473-E9464A1B-140D-4019-9C2F-D1D8976C842D @default.
- Q92774473 P31 Q92774473-E205C535-5375-4A26-8F90-D760E6739399 @default.
- Q92774473 P356 Q92774473-7B0DEE37-4CE1-4E41-8A80-0A4275D175FD @default.
- Q92774473 P407 Q92774473-8C230E08-76A2-4B77-AE13-08560BBA10E6 @default.
- Q92774473 P433 Q92774473-467A4318-0D89-4F5A-B2DF-509EC6FF0D70 @default.
- Q92774473 P478 Q92774473-783AD486-EBB2-43E6-A351-19860B85EEEA @default.
- Q92774473 P50 Q92774473-87AFDDD2-2161-4EF4-BC27-43C87B877C3D @default.
- Q92774473 P50 Q92774473-E91F139D-79F2-419F-BC58-7D39AD211059 @default.
- Q92774473 P577 Q92774473-EECF8369-2530-43FE-ACC0-46A0CC398DEF @default.
- Q92774473 P698 Q92774473-20775EE9-1D7B-44F8-9396-00AFBDF58D20 @default.
- Q92774473 P921 Q92774473-5087AF78-8A83-47E8-989D-C12D5D9A9290 @default.
- Q92774473 P921 Q92774473-980DFB05-C84F-4A17-8A7C-D008DE5A42F2 @default.
- Q92774473 P356 JRHEUM.190116 @default.
- Q92774473 P698 31203228 @default.
- Q92774473 P1433 Q7743623 @default.
- Q92774473 P1476 "Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis" @default.
- Q92774473 P2093 "Abhijit Shete" @default.
- Q92774473 P2093 "Atul Deodhar" @default.
- Q92774473 P2093 "Gerard Bruin" @default.
- Q92774473 P2093 "Iain B McInnes" @default.
- Q92774473 P2093 "Jorge Safi" @default.
- Q92774473 P2093 "Luminita Pricop" @default.
- Q92774473 P2093 "Ruvie Martin" @default.
- Q92774473 P2093 "Sebastian Spindeldreher" @default.
- Q92774473 P304 "539-547" @default.
- Q92774473 P31 Q13442814 @default.
- Q92774473 P356 "10.3899/JRHEUM.190116" @default.
- Q92774473 P407 Q1860 @default.
- Q92774473 P433 "4" @default.
- Q92774473 P478 "47" @default.
- Q92774473 P50 Q37605821 @default.
- Q92774473 P50 Q92751391 @default.
- Q92774473 P577 "2019-06-15T00:00:00Z" @default.
- Q92774473 P698 "31203228" @default.
- Q92774473 P921 Q511097 @default.
- Q92774473 P921 Q52849 @default.